Form D · Pharmaceuticals
LadeRx, LLC
Durham, NC · CIK 0001970543
Offering snapshot reported Apr 29, 2026 · SEC filing
- Reported sold
- Yet to sell Offering amount: $3M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 29, 2026 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Mar 27, 2023 | Initial | $66,669 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-582232
Source: Form D, filed Apr 29, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeff Clark | Executive |
| Banks Jefferson Clark | Executive |
| Christopher Lascola | Executive |
| Joseph K. Mc Caffrey | Executive |
| Margaret E. Smith | Executive |
| Lanty L. Smith | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3225 Surrey Road
Durham, NC, 27707
Phone: 919-949-4144
Durham, NC, 27707
Phone: 919-949-4144